Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON)

CUSIP: 254604101

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
37,778,373
Total 13F shares
19,115,397
Share change
+4,502,962
Total reported value
$848,710,699
Price per share
$44.40
Number of holders
89
Value change
+$223,083,623
Number of buys
71
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 254604101?
CUSIP 254604101 identifies IRON - Disc Medicine, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IRON - Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Braden M. Leonard
3/4/5
10%+ Owner
class O/S missing
5,247,500
$354,993,375 26 Oct 2022
Novo Holdings A/S
3/4/5 13F
10%+ Owner · Company
6.2%
from 13F
1,090,772
$73,790,726 28 Jun 2023
Atlas Venture Life Science Advisors, LLC
13F
Company
9.2%
3,461,784
$73,355,203 31 Mar 2023
13F
ORBIMED ADVISORS LLC
13F
Company
6%
2,269,637
$48,093,608 31 Mar 2023
13F
Bain Capital Life Sciences Investors, LLC
13F
Company
5.3%
1,990,914
$42,187,000 31 Mar 2023
13F
James B. Tananbaum
3/4/5
Director, 10%+ Owner
mixed-class rows
428,745
mixed-class rows
$27,837,975 04 Oct 2021
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
2.2%
826,936
$17,522,774 31 Mar 2023
13F
Atlas Venture Opportunity Fund II, L.P.
3/4/5
10%+ Owner
class O/S missing
218,326
$14,769,754 29 Dec 2022
5AM Venture Management, LLC
13F
Company
1.6%
588,442
$12,469,086 31 Mar 2023
13F
Logos Global Management LP
13F
Company
1.4%
525,000
$11,124,750 31 Mar 2023
13F
VANGUARD GROUP INC
13F
Company
0.85%
322,869
$6,841,594 31 Mar 2023
13F
Rock Springs Capital Management LP
13F
Company
0.83%
313,468
$6,642,387 31 Mar 2023
13F
Foresite Capital Management V, LLC
13F
Company
0.64%
243,513
$5,160,040 31 Mar 2023
13F
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
0.58%
220,013
$4,662,075 31 Mar 2023
13F
BML Capital Management, LLC
13F
Company
0.55%
208,161
$4,410,932 31 Mar 2023
13F
CITADEL ADVISORS LLC
13F
Company
0.45%
171,238
$3,628,533 31 Mar 2023
13F
FMR LLC
13F
Company
0.4%
151,699
$3,214,502 31 Mar 2023
13F
Boxer Capital, LLC
13F
Company
0.34%
130,000
$2,755,000 31 Mar 2023
13F
Trustees of Columbia University in the City of New York
13F
Company
0.29%
110,488
$2,341,241 31 Mar 2023
13F
Ghost Tree Capital, LLC
13F
Company
0.26%
100,000
$2,119,000 31 Mar 2023
13F
Nantahala Capital Management, LLC
13F
Company
0.24%
89,538
$1,897,310 31 Mar 2023
13F
ExodusPoint Capital Management, LP
13F
Company
0.19%
70,966
$1,504,000 31 Mar 2023
13F
Assenagon Asset Management S.A.
13F
Company
0.16%
61,805
$1,309,648 31 Mar 2023
13F
Brian Piekos
3/4/5
CFO
class O/S missing
17,615
$1,191,655 31 May 2022
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.12%
47,038
$996,735 31 Mar 2023
13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)
13F
Company
0.12%
45,750
$969,442 31 Mar 2023
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.12%
43,698
$925,960 31 Mar 2023
13F
Brian Richard MacDonald
3/4/5
Chief Innovation Officer
class O/S missing
13,372
$904,615 28 Jun 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.1%
37,213
$788,543 31 Mar 2023
13F
CITIGROUP INC
13F
Company
0.07%
25,080
$531,445 31 Mar 2023
13F
HARVARD MANAGEMENT CO INC
13F
Company
0.07%
25,000
$529,750 31 Mar 2023
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.06%
24,150
$511,739 31 Mar 2023
13F
BlackRock Finance, Inc.
13F
Company
0.06%
23,467
$497,265 31 Mar 2023
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.06%
22,107
$468,000 31 Mar 2023
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.06%
21,674
$459,272 31 Mar 2023
13F
JANE STREET GROUP, LLC
13F
Company
0.05%
19,252
$407,950 31 Mar 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.04%
15,270
$324,000 31 Mar 2023
13F
STATE STREET CORP
13F
Company
0.04%
14,487
$306,980 31 Mar 2023
13F
STIFEL FINANCIAL CORP
13F
Company
0.04%
13,722
$290,769 31 Mar 2023
13F
Velan Capital Investment Management LP
13F
Company
0.03%
12,269
$259,980 31 Mar 2023
13F
MORGAN STANLEY
13F
Company
0.03%
9,815
$207,981 31 Mar 2023
13F
BARCLAYS PLC
13F
Company
0.01%
5,619
$119,067 31 Mar 2023
13F
UBS Group AG
13F
Company
0.01%
5,243
$111,099 31 Mar 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.01%
2,682
$56,832 31 Mar 2023
13F
US BANCORP \DE\
13F
Company
0%
1,176
$24,919 31 Mar 2023
13F
Steward Partners Investment Advisory, LLC
13F
Company
0%
300
$6,357 31 Mar 2023
13F
ROYAL BANK OF CANADA
13F
Company
0%
100
$2,000 31 Mar 2023
13F
Ulland Investment Advisors, LLC
13F
Company
0%
34
$1,000 31 Mar 2023
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
26
$551 31 Mar 2023
13F
TCI Wealth Advisors, Inc.
13F
Company
0%
20
$424 31 Mar 2023
13F

Institutional Holders of Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) as of Q2 2023

As of 30 Jun 2023, Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) was held by 89 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,115,397 shares. The largest 10 holders included Atlas Venture Life Science Advisors, LLC, ORBIMED ADVISORS LLC, Bain Capital Life Sciences Investors, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Novo Holdings A/S, PERCEPTIVE ADVISORS LLC, Frazier Life Sciences Management, L.P., CITADEL ADVISORS LLC, VANGUARD GROUP INC, and BANK OF AMERICA CORP /DE/. This page lists 89 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
45
Q2 2023 holders
89
Holder diff
44
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 Value $ Q2 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .